The Food and Drug Administration conducted an inspection at M & L Pharmaceutical, Inc. in San Bernardino on April 28, assessing food composition, standards, labeling and economic factors, according to information published on the FDA’s website.
The agency’s final report found that M & L Pharmaceutical, Inc. was not required to make any changes to its management operations.
The FDA regularly inspects facilities nationwide to evaluate compliance with laws and regulations that support public health. The outcomes of these inspections are made available to the public.
The FDA’s website notes that the agency oversees the safety and quality of human and animal drugs, biological products, medical supplies and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
